Navigation Links
International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
Date:11/29/2007

GENEVA, Nov. 29 /PRNewswire-FirstCall/ -- The International Federation of Red Cross and Red Crescent Societies and Eli Lilly and Company, a multi- national pharmaceutical company, signed an agreement which will allow an eight-fold increase in the number of International Federation-supported programmes to fight multidrug-resistant tuberculosis (MDR-TB) over the next four years.

Lilly's 1.6 million USD contribution will finance programmes between 2008 and 2011. In 2008 alone, the International Federation will expand its support to 10 additional MDR-TB programmes in Kazakhstan, Uzbekistan, Romania, Georgia, Kenya, Mozambique and South Africa, for a total of 14 MDR-TB programmes.

"It is vital that tuberculosis patients complete their treatment, both to be cured, and to avoid a relapse into the more serious form of the disease, called multidrug-resistant TB, which is much more expensive and difficult to treat," explains Markku Niskala, secretary general of the International Federation. "We have noticed an increase of MDR-TB in certain regions, and it is essential we expand our programmes to help curb this trend. The Lilly funds will allow us to do that."

The first phase of the International Federation and Lilly MDR-TB Programme was implemented from 2004 to 2007 in three pilot countries. "Based on the success of the current programmes in Kazakhstan, Romania and Uzbekistan, we embrace the challenge of expanding this programme to cover more than ten countries," says Sidney Taurel, chairman and CEO of Lilly.

"These activities join those of a larger partnership of 14 public and private organisations around the world committed to fighting MDR-TB from every angle. We will continue to learn lessons from existing programmes and improve our initiatives to best serve those suffering from MDR-TB, and to best prevent its spread. We are committed, for the long-term, to triumph over the re-emergence of TB and MDR-TB."

Red Cross and Red Crescent TB programmes include providing patients with care, food and support, educating the community about the spread and symptoms of tuberculosis, detecting new cases through surveillance, and addressing the stigma associated with the disease. In addition, cured patients are often recruited as Red Cross and Red Crescent volunteers and provide invaluable psychological support to current patients. According to the World Health Organisation (WHO), community-based TB care significantly improves both access to services and adherence to treatment.

The WHO global TB control report for 2007 confirms progress has been made in recent years to control the TB pandemic, which kills 1.6 million people each year. But much more needs to be done. The European region, for example, has the highest level of TB treatment failures, and as a result, 15 percent of all new TB cases in the Baltic States, Eastern Europe and Central Asia are multidrug-resistant, a rate that is three times higher than in any other region in the world.

Currently, Red Cross and Red Crescent Societies in more than 20 countries address the needs of some 20,000 clients with TB and MDR-TB among the most vulnerable and marginalised groups in society - including the very poor, the homeless, the elderly, prisoners, and substance abusers. Many are also HIV- positive, and because of their weakened immune system, are at particular risk of dying from TB. To address this situation, many Red Cross and Red Crescent Societies are integrating their TB and HIV programmes, particularly in Asia (such as Myanmar) and in Africa (such as Kenya, Mozambique, South Africa and Zimbabwe).

The International Federation is an active partner in the Global Stop TB Partnership, whose aim is to decrease the prevalence and death rates of TB by 50 per cent by 2015.

(*) Tuberculosis is a very contagious disease, which spreads through the air. If not treated, every person with active TB infects, on average, 10 to 15 people each year.

The Federation, the national Red Cross and Red Crescent Societies and the International Committee of the Red Cross together constitute the International Red Cross and Red Crescent Movement. For further information on Federation activities, please see our web site: http://www.ifrc.org

The Lilly MDR-TB Partnership is a public-private initiative led by Eli Lilly and Company to address the expanding crisis of multi-drug resistant tuberculosis (MDR-TB) together with global health and relief organisations, academic institutions and private companies. Lilly has launched a multifaceted philanthropic programme to address MDR-TB. The Partnership is pursuing a comprehensive strategy to fight MDR-TB through increasing drug supply and discounting prices, conducting research, providing support for communities and training in prevention, treatment, and surveillance, and sharing drug manufacturing technology with nations most at risk. For further information on the Lilly MDR-TB Partnership, please go to http://www.lillymdr-tb.com

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology: